Trimetrexate
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101629This classification denotes a folate antagonist and dihydrofolate reductase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UPN4ITI8T4. European Medicines Agency schedules Trimetrexate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11312MIG. Trimetrexate generally arises in the molecular formula C19H23N5O3. The term TRIMETREXATE is an International Non-Proprietary Name or INN. TRIMETREXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trimetrexate under HS 29335995 and SITC 51576. As of Q4 2014, TRIMETREXATE remains the US FDA Preferred Term for this commodity. Trimetrexate bears US NLM identifiers UMLS ID C0085176 and NCI Concept Code C1314. SMILES: O(C1CC(NCC2C(C3C(NC([NH]C3N)N)CC2)C)CC(OC)C1OC)C.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.